Gamida Cell Ltd. logo

Gamida Cell Ltd.

NASDAQ:GMDA

Overview | Financials
Company Name Gamida Cell Ltd.
Symbol GMDA
Currency USD
Price 0.033
Market Cap 4,337,295
Dividend Yield 0%
52-week-range 0.03 - 2.51
Industry Biotechnology
Sector Healthcare
CEO Ms. Abigail L. Jenkins
Website https://www.gamida-cell.com

An error occurred while fetching data.

About Gamida Cell Ltd.

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in

Related Stocks

CorMedix Inc. logo

CorMedix Inc.

CRMD

5.76 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.467 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

9.65 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.3 USD

Cue Biopharma, Inc. logo

Cue Biopharma, Inc.

CUE

0.59 USD

Graphite Bio, Inc. logo

Graphite Bio, Inc.

GRPH

3.18 USD

Financials

Numbers are in millions USD

Numbers are in millions USD